Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | GBP 301 m |
| Total expense ratio | 0.18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | EUR |
| Currency risk | Currency unhedged |
| Volatility 1 year (in GBP) | 14.75% |
| Inception/ Listing Date | 20 September 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Amundi ETF |
| Fund Structure | Company With Variable Capital (SICAV) |
| UCITS compliance | Yes |
| Administrator | HSBC Securities Services (Ireland) DAC |
| Investment Advisor | |
| Custodian Bank | HSBC Bank PLC |
| Revision Company | - |
| Fiscal Year End | 31 December |
| Swiss representative | NO |
| Swiss paying agent | NO |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Eli Lilly & Co | 11.97% |
| AbbVie | 7.31% |
| UnitedHealth Group | 5.09% |
| AstraZeneca | 4.27% |
| Roche Holding | 3.94% |
| Merck & Co | 3.87% |
| Thermo Fisher Scientific | 3.62% |
| Novartis | 3.37% |
| Abbott Laboratories | 3.13% |
| Intuitive Surgical | 3.06% |
| United States | 68.00% |
| Switzerland | 9.37% |
| United Kingdom | 5.86% |
| Japan | 3.89% |
| Other | 12.88% |
| Health Care | 95.21% |
| Consumer Discretionary | 1.23% |
| Other | 3.56% |
| YTD | +1.72% |
| 1 month | +2.76% |
| 3 months | -0.79% |
| 6 months | +13.57% |
| 1 year | +0.70% |
| 3 years | +15.01% |
| 5 years | - |
| Since inception (MAX) | +14.87% |
| 2025 | +5.67% |
| 2024 | +2.75% |
| 2023 | +0.11% |
| 2022 | - |
| Volatility 1 year | 14.75% |
| Volatility 3 years | 13.04% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.05 |
| Return per risk 3 years | 0.37 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -17.00% |
| Maximum drawdown 3 years | -20.25% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -20.25% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | WELS | - - | - - | - |
| Euronext Paris | EUR | GLHL | GLHL FP IWELS | GLHL.PA IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
| SIX Swiss Exchange | USD | WEL9 | WEL9 SW WEL9USIV | WEL9.S IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
| XETRA | USD | WEL9 | WEL9 GY WEL9USIV | WELSGUSD.DE IWEL9USDINAV=SOLA | BNP Paribas Arbitrage |
| XETRA | EUR | WELS | WELS GY IWELS | WELSG.DE IWELSEURINAV=SOLA | BNP Paribas Arbitrage |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 908 | 0.40% p.a. | Accumulating | Sampling |
| iShares Ageing Population UCITS ETF | 583 | 0.40% p.a. | Accumulating | Sampling |
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Acc) | 303 | 0.18% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 23 | 0.35% p.a. | Accumulating | Full replication |
| Invesco S&P World Health Care ESG UCITS ETF Acc | 14 | 0.18% p.a. | Accumulating | Full replication |